Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05117112 · ClinicalTrials.gov registry record · NA
Nutritional Biomarkers of Sarcopenia
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05117112 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 30 participants.
The verdict
NCT05117112, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study proposes to characterize skeletal muscle amino acid kinetics to an EAA challenge, i.e., an oral amino acid tolerance test (OATT), in order to determine the state of muscle health. Analogous to the oral glucose tolerance test (OGTT) used to characterize alterations in glucose metabolism, the proposed OATT represents a potential low-cost solution to classifying patients' skeletal muscle health. The extrapolation of this work is the development of a simple analytical tool that would provide clinicians the ability to discern alterations in muscle amino acid kinetics prior to a loss of function.
Interventions
- DIETARY_SUPPLEMENT XS Muscle Multiplier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-08 |
| Est. Completion | 2023-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05117112
The ClinicalTrials.gov registry entry for NCT05117112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which XS Muscle Multiplier is the first listed.
NCT05117112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05117112 about?
NCT05117112 is a clinical study titled "Nutritional Biomarkers of Sarcopenia". This study proposes to characterize skeletal muscle amino acid kinetics to an EAA challenge, i.e., an oral amino acid tolerance test (OATT), in order to determine the state of muscle health. Analogous to the oral glucose tolerance test (OGTT) used to characterize alterations in glucose metabolism, t...
What is the current status of trial NCT05117112?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-08. Estimated completion is 2023-01-12.
What interventions are being tested in trial NCT05117112?
The interventions under investigation include: XS Muscle Multiplier (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05117112?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.